Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Gastroenterology · Colorectal Adenoma

How Is Recurrent Adenoma at a Polypectomy Scar Treated?

At a Glance

Many residual or recurrent adenomas at a colon polypectomy scar can be removed through the colonoscope, so recurrence does not automatically mean surgery. Pathology determines whether further endoscopic treatment is safe or whether advanced endoscopy or segmental colon surgery is needed.

Finding new tissue at the scar where a polyp was previously removed can be stressful, but it does not automatically mean you have cancer or need a surgical bowel resection. Finding residual adenoma (tissue left behind from the original removal) or recurrent adenoma (tissue that grew back after apparent clearance) is a known possibility, especially if the original polyp was large or removed in pieces [1].

Many of these cases can be completely and safely removed endoscopically (through the colonoscope). In specialized studies, endoscopic treatment successfully managed the majority of recurrences, while a small minority required surgery [2] [3]. However, your individual chances depend on the size, location, and pathology of your specific tissue, as well as the expertise of your endoscopist.

Why Does Tissue Return and How Is It Found?

When a large polyp (often 20 millimeters or larger) cannot be safely removed in one piece, doctors use a technique called piecemeal resection to remove it in smaller fragments [1]. Removing it in pieces increases the chance that microscopic adenoma cells are left behind at the edges.

Because of this, guidelines commonly recommend a follow-up colonoscopy to carefully inspect the scar, often around 3 to 6 months after the initial piecemeal removal [4] [5]. During this procedure, the doctor uses high-definition white-light inspection, often supplemented by dye-based or virtual chromoendoscopy (specialized lighting techniques like narrow-band imaging), to closely examine the scar [6] [7].

Endoscopic Treatment Options

While small, simple recurrences might be treated safely during the same colonoscopy, larger or more complex tissue is often biopsied and deferred so you can be referred to an advanced endoscopist [2].

When visible adenomatous tissue is found, the primary goal is to physically remove it for pathological testing, not just burn it away [8].

  • Snare Resection and EMR: The standard approach is to use a wire loop (snare) to capture and remove the visible tissue. Often, fluid is injected under the tissue to lift it away from the deeper colon wall—a procedure called Endoscopic Mucosal Resection (EMR) [9].
  • Avulsion and Coagulation: For selected tiny or difficult residual islands of tissue that cannot be captured with a snare, an expert may use forceps to pluck the tissue away, followed by heat (coagulation) on the remaining edges [9] [10].
  • Margin Ablation: Doctors may use heat or argon plasma coagulation (APC) to treat the edges of the scar to prevent future recurrence. Ablation is an extra step used after the visible tissue has been physically removed, not a replacement for removing it [8] [11].

Advanced Endoscopy for Difficult Scars

Sometimes, the previous removal causes dense fibrosis (scar tissue). This can make the new adenoma tissue stick tightly to the colon wall, preventing it from lifting when fluid is injected [12]. A “non-lifting” scar is often just fibrosis, but it can sometimes raise suspicion for cancer growing deeper into the wall; it requires expert assessment rather than assuming either possibility [13] [14].

An advanced endoscopist may recommend specialized, selective procedures, which carry their own risks and require expert training:

  • Endoscopic Submucosal Dissection (ESD): The doctor uses a specialized microscopic knife to carefully dissect and peel away the scar tissue and adenoma in one piece [12]. It is highly effective but can be technically difficult in dense scar tissue and carries risks of bleeding and perforation [15].
  • Endoscopic Full-Thickness Resection (EFTR): For selected lesion sizes and locations, a specialized device removes a full-thickness layer of the colon wall and immediately closes the hole with a clip [16]. While it can avoid segmental surgery, it carries risks such as clip-related problems or incomplete resection [16].

The Role of Pathology and When Surgery is Necessary

Colonoscopy is a visual procedure. The final decision on your treatment relies heavily on pathology—the microscopic examination of the removed tissue.

Surgery (removing a segment of the colon and nearby lymph nodes) is generally reserved for situations guided by multidisciplinary review, such as:

  • High-Risk Cancer Features: If pathology confirms invasive cancer with high-risk features (such as growing deep into the submucosal layer, invading lymph vessels, having poor cell differentiation, or positive/uncertain margins), surgery is usually recommended to ensure all cancer and potentially affected lymph nodes are removed [17] [18].
  • Technical Limits: If dense scarring, difficult anatomy, or lesion size makes it unsafe or impossible to completely clear the tissue endoscopically [19] [20].

Risks and When to Seek Help

Endoscopic treatments, especially advanced procedures, carry risks including bleeding, perforation (a tear in the colon wall), and reactions to sedation [15] [16]. After any treatment, you should seek urgent medical care if you experience severe or worsening abdominal pain, fever, faintness, or heavy/persistent rectal bleeding.

Common questions in this guide

Does finding adenoma again at a polypectomy scar mean it is cancer?
No. Residual or recurrent adenoma does not automatically mean cancer, but the removed tissue must be examined by a pathologist to determine whether invasive cancer is present and what treatment is appropriate.
Can a recurrent adenoma be removed without bowel surgery?
Often, yes. Many recurrences can be removed through the colonoscope with a snare or endoscopic mucosal resection, but dense scarring, difficult anatomy, incomplete clearance, or high-risk cancer features may make surgery safer.
Why is visible tissue removed instead of only being burned?
Visible adenomatous tissue should usually be physically removed and sent to pathology so its type and margins can be assessed. Heat or argon plasma coagulation may be used on scar edges after removal, but it is not a substitute for removing visible tissue.
What does a non-lifting scar after polyp removal indicate?
A scar that does not lift when fluid is injected often reflects fibrosis, or dense scar tissue, from the earlier procedure. It can sometimes raise concern that cancer extends deeper into the colon wall, so an advanced endoscopist should assess it rather than assuming either cause.
When would surgery be recommended for adenoma at a scar?
Surgery is generally considered when pathology shows invasive cancer with high-risk features or when scarring, anatomy, or lesion size makes complete endoscopic removal unsafe or impossible. The operation may remove a segment of colon and nearby lymph nodes.
How soon is follow-up colonoscopy needed after piecemeal polyp removal?
Guidelines commonly recommend inspecting the scar about 3 to 6 months after piecemeal removal of a large polyp, often 20 millimeters or larger. Your gastroenterologist may adjust the interval based on the original pathology, completeness of removal, and follow-up findings.
What symptoms require urgent medical care after treatment?
Seek urgent medical care for severe or worsening abdominal pain, fever, faintness, or heavy or persistent rectal bleeding after treatment. Follow your discharge instructions and use the contact number provided by your endoscopy team if you are unsure how serious a symptom is.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on colon adenoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was all visible tissue removed and sent to pathology, or will I need to be referred to an advanced endoscopist?
  2. 2.What did the pathology report show regarding the tissue type (adenoma vs. cancer) and whether the margins are clear?
  3. 3.What is my individual estimated chance of complete endoscopic removal, and what are the specific risks (like bleeding or perforation) for the planned technique?
  4. 4.How long should I wait before my next surveillance colonoscopy, and how is that interval determined for my specific case?
  5. 5.Should my case be reviewed by a multidisciplinary colorectal team?

References

References (20)
  1. 1

    Risk factors for local recurrence and appropriate surveillance interval after endoscopic resection.

    Komeda Y, Watanabe T, Sakurai T, et al.

    World journal of gastroenterology 2019; (25(12)):1502-1512 doi:10.3748/wjg.v25.i12.1502.

    PMID: 30948913
  2. 2

    Treatment of adenoma recurrence after endoscopic mucosal resection.

    Tate DJ, Desomer L, Argenziano ME, et al.

    Gut 2023; (72(10)):1875-1886 doi:10.1136/gutjnl-2023-330300.

    PMID: 37414440
  3. 3

    Efficacy and safety of salvage endoscopy in the treatment of residual or recurrent colorectal neoplasia after endoscopic resection: a systematic review and meta-analysis.

    Du J, Zhang T, Wang L, et al.

    Surgical endoscopy 2024; (38(6)):3027-3034 doi:10.1007/s00464-024-10879-8.

    PMID: 38744694
  4. 4

    Delayed surveillance colonoscopy after piecemeal EMR is not associated with increased recurrence rates.

    Arraf T, Gorelik Y, Mazzawi F, et al.

    Endoscopy international open 2026; (14()):a28164998 doi:10.1055/a-2816-4998.

    PMID: 41970668
  5. 5

    Outcomes of Thermal Ablation of the Mucosal Defect Margin After Endoscopic Mucosal Resection: A Prospective, International, Multicenter Trial of 1000 Large Nonpedunculated Colorectal Polyps.

    Sidhu M, Shahidi N, Gupta S, et al.

    Gastroenterology 2021; (161(1)):163-170.e3 doi:10.1053/j.gastro.2021.03.044.

    PMID: 33798525
  6. 6

    Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2019.

    Bisschops R, East JE, Hassan C, et al.

    Endoscopy 2019; (51(12)):1155-1179 doi:10.1055/a-1031-7657.

    PMID: 31711241
  7. 7

    Linked-color imaging versus high definition white-light endoscopy for evaluation of post-polypectomy scars of nonpedunculated lesions: LCI-Scar study.

    Ortiz O, Daca-Alvarez M, Rivero-Sánchez L, et al.

    Endoscopy 2024; (56(4)):283-290 doi:10.1055/a-2204-3236.

    PMID: 37931908
  8. 8

    Avulsion is superior to argon plasma coagulation for treatment of visible residual neoplasia during EMR of colorectal polyps (with videos).

    Holmes I, Kim HG, Yang DH, Friedland S

    Gastrointestinal endoscopy 2016; (84(5)):822-829 doi:10.1016/j.gie.2016.03.1512.

    PMID: 27080417
  9. 9

    Treatment strategy for local recurrences after endoscopic resection of a colorectal neoplasm.

    Ito S, Hotta K, Imai K, et al.

    Surgical endoscopy 2019; (33(4)):1140-1146 doi:10.1007/s00464-018-6373-z.

    PMID: 30043171
  10. 10

    Impact of margin thermal ablation after cold-forceps avulsion with snare-tip soft coagulation for nonlifting large nonpedunculated colorectal polyps.

    Mandarino FV, O'Sullivan T, Gauci JL, et al.

    Endoscopy 2025; (57(7)):730-739 doi:10.1055/a-2535-7559.

    PMID: 39919821
  11. 11

    Cold-forceps avulsion with adjuvant snare-tip soft coagulation (CAST) is an effective and safe strategy for the management of non-lifting large laterally spreading colonic lesions.

    Tate DJ, Bahin FF, Desomer L, et al.

    Endoscopy 2018; (50(1)):52-62 doi:10.1055/s-0043-119215.

    PMID: 29020690
  12. 12

    Effectiveness and safety of endoscopic submucosal dissection for residual or recurrent colorectal neoplasia: Meta-analysis.

    Eisele M, Ceccacci A, Gupta M, et al.

    Endoscopy international open 2025; (13()):a26060982 doi:10.1055/a-2606-0982.

    PMID: 40611847
  13. 13

    Colonoscopic-Assisted Laparoscopic Wedge Resection for Colonic Lesions: A Prospective Multicenter Cohort Study (LIMERIC-Study).

    Leicher LW, Huisman JF, van Grevenstein WMU, et al.

    Annals of surgery 2022; (275(5)):933-939 doi:10.1097/SLA.0000000000005417.

    PMID: 35185125
  14. 14

    Endoscopic full-thickness resection using a clip non-exposed method for gastrointestinal tract lesions: a meta-analysis.

    Brewer Gutierrez OI, Akshintala VS, Ichkhanian Y, et al.

    Endoscopy international open 2020; (8(3)):E313-E325 doi:10.1055/a-1073-7593.

    PMID: 32118105
  15. 15

    Efficacy of the pocket-creation method with a traction device in endoscopic submucosal dissection for residual or recurrent colorectal lesions.

    Ide D, Ohya TR, Ishioka M, et al.

    Clinical endoscopy 2022; (55(5)):655-664 doi:10.5946/ce.2022.009.

    PMID: 35636748
  16. 16

    Use of endoscopic submucosal dissection or full-thickness resection device to treat residual colorectal neoplasia after endoscopic resection: a multicenter historical cohort study.

    Yzet C, Le Baleur Y, Albouys J, et al.

    Endoscopy 2023; (55(11)):1002-1009 doi:10.1055/a-2116-9930.

    PMID: 37500072
  17. 17

    Recurrent colorectal cancer after endoscopic resection when additional surgery was recommended.

    Takatsu Y, Fukunaga Y, Hamasaki S, et al.

    World journal of gastroenterology 2016; (22(7)):2336-41 doi:10.3748/wjg.v22.i7.2336.

    PMID: 26900295
  18. 18

    Long-term clinical outcomes of endoscopic submucosal dissection for colorectal neoplasms in 423 cases: a retrospective study.

    Yamada M, Saito Y, Takamaru H, et al.

    Endoscopy 2017; (49(3)):233-242 doi:10.1055/s-0042-124366.

    PMID: 28107766
  19. 19

    AGA Clinical Practice Update on Appropriate and Tailored Polypectomy: Expert Review.

    Copland AP, Kahi CJ, Ko CW, Ginsberg GG

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024; (22(3)):470-479.e5 doi:10.1016/j.cgh.2023.10.012.

    PMID: 38032585
  20. 20

    Experience in colon sparing surgery in North America: advanced endoscopic approaches for complex colorectal lesions.

    Gorgun E, Benlice C, Abbas MA, Steele S

    Surgical endoscopy 2018; (32(7)):3114-3121 doi:10.1007/s00464-018-6026-2.

    PMID: 29362906

This page explains treatment options for residual or recurrent adenoma at a colon polypectomy scar for educational purposes only and is not medical advice. Your gastroenterologist, pathologist, and colorectal team should interpret your findings and recommend the safest plan.